Smoking Cessation Growth Opportunities Lay With Employers, Health Care Reform
This article was originally published in The Tan Sheet
Many employers still hold a short-sighted view of the cost of smoking cessation therapies, panelists at an American University webinar said Nov. 16.
You may also be interested in...
Speakers at a workshop on nicotine-replacement therapy point abroad for guidance on expanding indications for smoking-cessation products as an FDA official says the agency likely will put the question before an advisory committee.
A 1study showing that the financial benefits of government subsidies for smoking cessation programs outweigh their costs prompts advocates and researchers to urge Medicaid coverage for the products, which could boost product sales
FDA's stated commitment to a public health approach to drug regulation will be put to the test by a petition to expand nicotine replacement therapy indications and availability